Back to BlackRock, Inc. BlackRock, Inc.

SRPTSRPT
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in AVI BIOPHARMA INC

BlackRock, Inc. holds 19M shares of SRPT (AVI BIOPHARMA INC), worth $341.3M as of 2026-Q2. The position was increased (+28.7% shares). SRPT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$341.3M

Current Shares

19M

Total Value Change

-$1B

Total Shares Change

+7.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
19M
+28.7%
$341.3M0.0%$17.97
39
2026-Q1
Increased
14.8M
+3.3%
$321.1M0.0%$15.87
32
2025-Q4
Increased
14.3M
+8.2%
$307.4M0.0%$21.49
34
2025-Q3
Increased
13.2M
+8.9%
$254.4M0.0%$18.82
34
2025-Q2
Increased
12.1M
+22.3%
$207.2M0.0%$17.11
37
2025-Q1
Decreased
9.9M
-11.5%
$632.3M0.0%$70.41
0
2024-Q4
New
11.2M
-
$1.4B0.0%$121.19
44

Other major holders of SRPT: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., Janus Henderson Group Ltd., Capital Research Global Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used